Morton Community Bank Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Morton Community Bank boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.2% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 8,182 shares of the healthcare conglomerate’s stock after purchasing an additional 475 shares during the period. UnitedHealth Group makes up approximately 1.2% of Morton Community Bank’s portfolio, making the stock its 21st biggest holding. Morton Community Bank’s holdings in UnitedHealth Group were worth $4,167,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Signature Resources Capital Management LLC boosted its position in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC lifted its position in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after acquiring an additional 18 shares in the last quarter. GoalVest Advisory LLC grew its holdings in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares in the last quarter. Continuum Advisory LLC lifted its stake in UnitedHealth Group by 0.6% in the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock worth $1,737,000 after acquiring an additional 19 shares in the last quarter. Finally, Veracity Capital LLC increased its holdings in shares of UnitedHealth Group by 1.5% in the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock valued at $660,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 0.2 %

NYSE UNH traded up $1.39 during trading on Friday, reaching $596.88. 2,926,369 shares of the stock traded hands, compared to its average volume of 4,070,939. The firm has a market cap of $549.36 billion, a price-to-earnings ratio of 36.48, a price-to-earnings-growth ratio of 1.68 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock’s 50-day moving average price is $558.98 and its 200 day moving average price is $515.11.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter last year, the business posted $6.14 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

Several research firms have weighed in on UNH. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Monday, August 19th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Truist Financial raised their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. TD Cowen increased their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.